312 related articles for article (PubMed ID: 30604390)
1. Monoclonal Antibodies for Multiple Sclerosis: An Update.
Graf J; Aktas O; Rejdak K; Hartung HP
BioDrugs; 2019 Feb; 33(1):61-78. PubMed ID: 30604390
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in the treatment of multiple sclerosis.
Di Pauli F; Berger T; Reindl M
Curr Med Chem; 2009; 16(36):4858-68. PubMed ID: 19929782
[TBL] [Abstract][Full Text] [Related]
3. [Monoclonal antibodies for the treatment of multiple sclerosis].
Sánchez-Seco VG; Casanova Peño I; Arroyo González R
Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies in treatment of multiple sclerosis.
Rommer PS; Dudesek A; Stüve O; Zettl UK
Clin Exp Immunol; 2014 Mar; 175(3):373-84. PubMed ID: 24001305
[TBL] [Abstract][Full Text] [Related]
5. Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Deiß A; Brecht I; Haarmann A; Buttmann M
Expert Rev Neurother; 2013 Mar; 13(3):313-35. PubMed ID: 23448220
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Wingerchuk DM; Carter JL
Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
[TBL] [Abstract][Full Text] [Related]
7. Treating multiple sclerosis with monoclonal antibodies: a 2010 update.
Buttmann M
Expert Rev Neurother; 2010 May; 10(5):791-809. PubMed ID: 20420497
[TBL] [Abstract][Full Text] [Related]
8. Established and novel disease-modifying treatments in multiple sclerosis.
Cross AH; Naismith RT
J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of the safety and efficacy of monoclonal antibodies for progressive multiple sclerosis.
Sabahi Z; Daei Sorkhabi A; Sarkesh A; Naseri A; Asghar-Rezaei N; Talebi M
Int Immunopharmacol; 2023 Jul; 120():110266. PubMed ID: 37209514
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of monoclonal antibody therapies for relapsing remitting multiple sclerosis: A network meta-analysis.
Xu X; Chi S; Wang Q; Li C; Xu B; Zhang J; Chen X
Mult Scler Relat Disord; 2018 Oct; 25():322-328. PubMed ID: 30195200
[TBL] [Abstract][Full Text] [Related]
11. Safety profile of Tysabri: international risk management plan.
Iaffaldano P; D'Onghia M; Trojano M
Neurol Sci; 2009 Oct; 30 Suppl 2():S159-62. PubMed ID: 19882366
[TBL] [Abstract][Full Text] [Related]
12. Novel monoclonal antibodies for therapy of multiple sclerosis.
Knier B; Hemmer B; Korn T
Expert Opin Biol Ther; 2014 Apr; 14(4):503-13. PubMed ID: 24579720
[TBL] [Abstract][Full Text] [Related]
13. Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Singer BA
Semin Neurol; 2016 Apr; 36(2):140-7. PubMed ID: 27116720
[TBL] [Abstract][Full Text] [Related]
14. Novel Agents for Relapsing Forms of Multiple Sclerosis.
Straus Farber R; Harel A; Lublin F
Annu Rev Med; 2016; 67():309-21. PubMed ID: 26394285
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of antibody therapy in demyelinating diseases.
Akaishi T; Nakashima I
Int Immunol; 2017 Jul; 29(7):327-335. PubMed ID: 28910968
[TBL] [Abstract][Full Text] [Related]
16. Treating multiple sclerosis with monoclonal antibodies.
Buttmann M; Rieckmann P
Expert Rev Neurother; 2008 Mar; 8(3):433-55. PubMed ID: 18345973
[TBL] [Abstract][Full Text] [Related]
17. [Biological treatment of multiple sclerosis].
Sørensen PS; Sellebjerg F
Ugeskr Laeger; 2008 Jun; 170(24):2156-9. PubMed ID: 18565303
[TBL] [Abstract][Full Text] [Related]
18. Emerging monoclonal antibody therapies for multiple sclerosis.
Cree B
Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
[TBL] [Abstract][Full Text] [Related]
19. Alemtuzumab and multiple sclerosis: therapeutic application.
Minagar A; Alexander JS; Sahraian MA; Zivadinov R
Expert Opin Biol Ther; 2010 Mar; 10(3):421-9. PubMed ID: 20095876
[TBL] [Abstract][Full Text] [Related]
20. Safety of monoclonal antibodies for the treatment of multiple sclerosis.
McGinley MP; Moss BP; Cohen JA
Expert Opin Drug Saf; 2017 Jan; 16(1):89-100. PubMed ID: 27756172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
